Silk Road Medical (NASDAQ: SILK)
Silk Road Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Silk Road Medical Company Info
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.
News & Analysis
Why Shares of Silk Road Medical Are Dropping Wednesday
The company's CEO stepped down and the company reduced top-line yearly guidance.
Why Shares of Silk Road Medical Are Dropping Wednesday
A prospective change by the Centers for Medicare & Medicaid Services could hurt the company's revenue growth.
Why Silk Road Medical Stock Is Sinking Today
Investors responded negatively to the medical device company's pricing of a public stock offering.
Is Silk Road Medical a Buy?
Less than a year after it went public, should investors be excited about this stroke-prevention biotech?
Could This Stroke-Prevention Specialist Be the Next Great Growth Stock?
This newly public company is growing at breakneck speed and has a massive opportunity ahead of it.
Valuation
Earnings Transcripts
Silk Road Medical, inc (SILK) Q3 2021 Earnings Call Transcript
SILK earnings call for the period ending September 30, 2021.
Silk Road Medical, inc (SILK) Q2 2021 Earnings Call Transcript
SILK earnings call for the period ending June 30, 2021.
SILK ROAD MEDICAL INC (SILK) Q1 2021 Earnings Call Transcript
SILK earnings call for the period ending March 31, 2021.
SILK ROAD MEDICAL INC (SILK) Q4 2020 Earnings Call Transcript
SILK earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.